Chinese General Practice ›› 2018, Vol. 21 ›› Issue (26): 3201-3205.DOI: 10.12114/j.issn.1007-9572.2018.00.125
• Monographic Research • Previous Articles Next Articles
Published:
2018-09-15
Online:
2018-09-15
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2018.00.125
[1]World Health Organization.10 facts on diabetes[EB/OL].(2016-04)[2018-02-20].http://www.who.int/features/factfiles/diabetes/en/.3204 [2]International Diabetes Federation.IDF world diabetes day 2017 event[EB/OL].(2017-11-14)[2018-02-20].https://www.idf.org/341-homepage/wdd-2017/329-idf-world-diabetes-day-2017-event.html.3204 [3]BOMMER C,HEESEMANN E,SAGALOVA V,et al.The global economic burden of diabetes in adults aged 20-79 years:acost-of-illness study[J].Lancet Diabetes Endocrinol,2017,5(6):423-430.DOI:10.1016/S2213-8587(17)30097-9.3204 [4]YANG W,LU J,WENG J,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.DOI:10.1056/NEJMoa0908292.3204 [5]上海市疾病预防控制中心.2013上海市慢性病及其危险因素监测报告[M].上海:上海科学普及出版社,2014:50.3204 Shanghai Municipal Center for Disease Control & Prevention.2013 Shanghai chronic diseases and risk factors monitoring report[M].Shanghai:Shanghai Science Popularization Press,2014:50.3204 [6]LIN C C,LI C I,HSIAO C Y,et al.Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007:a population-based study[J].BMC Public Health,2013,13:318.DOI:10.1186/1471-2458-13-318.3204 [7]LEE T T,CHENG S H,CHEN C C,et al.A pay-for-performance program for diabetes care in Taiwan:a preliminary assessment[J].Am J Manag Care,2010,16(1):65-69.3204 [8]纪立农.丰富中国2型糖尿病防治措施的临床证据链,建立基于中国人群证据的糖尿病防治指南——纪念第1版《中国2型糖尿病防治指南》发布10周年[J].中国糖尿病杂志,2014,22 (1):1-4.DOI:10.3969/j.issn.1006-6187.2014.01.001.3204 JI L N.Develop Chinese diabetes guidelines from clinical evidence in China——marking the tenth anniversary of the first edition of Chinese diabetes guidelines for type 2 diabetes[J].Chinese Journal of Diabetes,2014,22(1):1-4.DOI:10.3969/j.issn.1006-6187.2014.01.001.3204 [9]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2007年版)[J].中华医学杂志,2008,94(18):1227-1245. 3204 Chinese Diabetes Society.Guidelines for the prevention and treatment of type 2 diabetes in China(2007 edition)[J].National Medical Journal of China,2008,94(18):1227-1245. 3204 [10]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国糖尿病杂志,2012,20(1):81-117.3204 Chinese Diabetes Society.Guidelines for the prevention and treatment of type 2 diabetes in China (2010 edition)[J].Chinese Journal of Diabetes,2012,20(1):81-117.3204 [11]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,6(7):447-498.DOI:10.3760/cma.j.issn.1674-5809.2014.07.004.3204 Chinese Diabetes Society.Guidelines for the prevention and treatment of type 2 diabetes in China(2013 edition)[J].Chinese Journal of Diabetes Mellitus,2014,6(7):447-498.DOI:10.3760/cma.j.issn.1674-5809.2014.07.004.3204 [12]上海市卫生和计划生育委员会.关于印发《上海市社区高血压防治工作指南(试行)》和《上海市社区糖尿病防治工作指南(试行)》的通知[EB/OL].(2004-11-16)[2018-02-20].http://www.wsjsw.gov.cn/wsj/n429/n432/n1487/n1507/u1ai82243.html.3204 [13]上海市卫生和计划生育委员会.关于印发《上海市社区健康管理工作规范——慢性病综合防治(2017年版本)》的通知[EB/OL].(2017-02-27)[2018-02-20].http://www.popinfo.gov.cn/wsj/n429/n432/n2354/n1542/u1ai140138.html.3204 [14]李锐,杨群娣,施亮,等.上海市社区糖尿病患者管理服务模式及方法初探[J].药品评价,2008,5(4):185-187.DOI:10.3969/j.issn.1672-2809.2008.04.013.3204 LI R,YANG Q D,SHI L,et al.Shanghai community diabetes management model and method discussion[J].Drug Evaluation,2008,5(4):185-187.DOI:10.3969/j.issn.1672-2809.2008.04.013.3204 [15]李锐,施亮,杨群娣,等.上海市社区管理2型糖尿病患者血糖控制和用药情况[J].环境与职业医学,2016,33(4):329-333.DOI:10.13213/j.cnki.jeom.2016.15274.3205 LI R,SHI L,YANG Q D,et al.Glycemic control and medication compliance of type 2 diabetes in community management system in Shanghai[J].Journal of Environmental & Occupational Medicine,2016,33(4):329-333.DOI:10.13213/j.cnki.jeom.2016.15274.3205 [16]舒明.基于健康云平台的机构医养结合模式探讨[J].上海预防医学,2017,29(8):616-617.DOI:10.19428/j.cnki.sjpm.2017.08.009.3205 SHU M.Research on the combination of medical doctors and Yang Yang based on health cloud platform[J].Shanghai Journal of Preventive Medicine,2017,29(8):616-617.DOI:10.19428/j.cnki.sjpm.2017.08.009.3205 [17]WANG C Y,YU N C,SHEU W H,et al.Team care of type 2 diabetes mellitus in Taiwan[J].Diabetes Res Clin Pract,2014,106(Suppl 2):S309-313.DOI:10.1016/S0168-8227(14)70735-1.3205 [18]CHENG T M.Taiwan's new National Health Insurance program:genesis and experience so far[J].Health Aff(Millwood),2003,22(3):61-76.DOI:10.1377/hlthaff.22.3.61.3205 [19]中华人民共和国国家卫生健康委员会.2015年我国卫生和计划生育事业发展统计公报[EB/OL].(2016-07-20)[2018-02-20].http://www.nhfpc.gov.cn/guihuaxxs/s10748/201607/da7575d64fa04670b5f375c87b6229b0.shtml.3205 [20]张晓燕,张传政,赵列宾,等.按绩效付费模式(P4P)在优化糖尿病管理中的应用[J].中国卫生资源,2014,7(5):351-354.DOI:10.3969/j.issn.1007-953X.2014.05.013.3205 ZHANG X Y,ZHANG C Z,ZHAO L B,et al.The application of pay for performance(P4P)in improving diabetes control[J].Chinese Health Resources,2014,7(5):351-354.DOI:10.3969/j.issn.1007-953X.2014.05.013.3205 [21]CHANG R E,LIN S P,ARON D C.A pay-for-performance program in Taiwan improved care for some diabetes patients,but doctors may have excluded sicker ones[J].Health Aff(Millwood),2012,31(1):93-102.DOI:10.1377/hlthaff.2010.0402.3205 [22]LIN T Y,CHEN C Y,HUANG Y T,et al.The effectiveness of a pay for performance program on diabetes care in Taiwan:a nationwide population-based longitudinal study[J].Health Policy,2016,120(11):1313-1321.DOI:10.1016/j.healthpol.2016.09.014.3205 [23]JIANG Y D,SHIU R S,CHUANG L M,et al.Is the development of a diabetes care system important for quality care? An analysis in Taiwan[J].J Diabetes Investing,2011,2(2):79-81.DOI:10.1111/j.2040-1124.2011.00110.x.3205 [24]新华网.糖尿病管理的“上海探索”[EB/OL].(2017-12-13)[2018-02-20].http://news.xinhuanet.com/health/2017-12/13/c_1122101794.htm.3205 Xinhua Net.Diabetes management of“Shanghai exploration” [EB/OL].(2017-12-13)[2018-02-20].http://news.xinhuanet.com/health/2017-12/13/c_1122101794.htm.3205 [25]WU T Y,MAJEED A,KUO K N.An overview of the healthcare system in Taiwan[J].London J Prim Care(Abingdon),2010,3(2):115-119.3205 [26]尤川梅,王芳,姚楠,等.我国社区卫生服务机构绩效考核中的问题分析[J].中国卫生政策研究,2011,4(2):40-44.DOI:10.3969/j.issn.1674-2982.2011.02.009.3205 YOU C M,WANG F,YAO N,et al.Analysis of the problems in implementing performance evaluation on community health service institutions[J].Chinese Journal of Health Policy,2011,4(2):40-44.DOI:10.3969/j.issn.1674-2982.2011.02.009.3205 [27]姚岚,龚勋,熊巨洋,等.社区卫生服务中心个人绩效考核方案初探[J].中国卫生经济,2007,12(26):13-15.DOI:10.3969/j.issn.1003-0743.2007.12.005.3205 YAO L,GONG X,XIONG J Y,et al.Discuss personal performance appraise in the community health service center[J].Chinese Health Economics,2007,12(26):13-15.DOI:10.3969/j.issn.1003-0743.2007.12.005.3205 |
[1] | GU Hanxin, LIU Yang, LIU Yuanli. Falls Prevention Intervention for Community-dwelling Older Adults from the Perspective of Policy Tools: an International Comparative Study [J]. Chinese General Practice, 2023, 26(34): 4231-4238. |
[2] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[3] | LIN Kai, YAO Mi, CHEN Zhang, JI Xinxin, LIN Runqi, CHEN Yongsong, Sim MOIRA. Conceptual Framework and Responding Approach of Treatment Burden of Type 2 Diabetes: a Video Recording-based Analysis [J]. Chinese General Practice, 2023, 26(34): 4302-4307. |
[4] | HUANG Jinling, ZENG Zhirong. The Logic and Trend of Urban Community Health Service Policies in China [J]. Chinese General Practice, 2023, 26(34): 4239-4245. |
[5] | YANG Hui, HU Ruwei, LIU Ruqing, LU Junfeng, WU Jinglan. Relationship between Community Health Service Experience and Glycemic Control Outcomes in Patients with Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(34): 4290-4295. |
[6] | ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019. |
[7] | CHENG Jingwei, QIAO Junjun, YIN Zhen, HU Junpeng, WANG Qinghe, LIU Yangqing, WANG Yanfang. Interpretation of ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes [J]. Chinese General Practice, 2023, 26(30): 3719-3724. |
[8] | ZHOU Xiaoqi, LIU Xinhui, ZHANG Wei, LI Changfeng, YAN Yaqiong. Association of Alanine Transaminase and Aspartate Aminotransferase/Alanine Transaminase Ratio with Type 2 Diabetes and Metabolic Syndrome in the Elderly [J]. Chinese General Practice, 2023, 26(29): 3645-3649. |
[9] | ZHAO Xiaohua, DU Lin, GAO Shengnan, JIANG Ziyun. Multiple Deep Muscle Abscesses in Type 2 Diabetes in the Elderly: Report of One Case and Literature Review [J]. Chinese General Practice, 2023, 26(29): 3715-3718. |
[10] | PU Haifeng, WANG Yinsheng, YU Changyin, CHEN Lingli, XIAO Xue, ZHANG Nian, CHEN Chuying, ZHU Jiming. Current Situation, Problems, and Strategies of Continuing Medical Education for Rural Order-oriented General Practitioners in Guizhou Province [J]. Chinese General Practice, 2023, 26(28): 3551-3558. |
[11] | LUO Dan, XU Jingjing, WANG Yubing, LI Mingzi, FORBES Angus. Development and Preliminary Practice of Resilience-oriented Structured Treatment and Educational Program for Adolescents with Type 1 Diabetes [J]. Chinese General Practice, 2023, 26(27): 3423-3429. |
[12] | DONG Yanan, JIANG Xiaorui, WANG Kai, ZONG Chuanchong, LIN Guodong, LI Xiangqing, LIN Chunxiao, CHI Juntao. The Effect of Modified Tibial Transverse Transport Technique in the Treatment of Wagner Grade Ⅲ and Ⅳ Diabetic Foot Patients [J]. Chinese General Practice, 2023, 26(27): 3411-3416. |
[13] | CHEN Lunwen, ZHOU Yang, YAN Guodong, SHEN Yi, SUN Chen, CAI Wanli, CHU Minjie, XIAO Jing. Risk of Malignant Tumor in Patients with Type 2 Diabetes: a Prospective Population-based Study [J]. Chinese General Practice, 2023, 26(26): 3238-3245. |
[14] | FEI Sijie, ZHANG Qiang, LIU Fangfang, BAI Lu, SUN Caihong, XIN Caifeng. Correlation between Glycated Hemoglobin Variability and New-onset Atrial Fibrillation in Type 2 Diabetes Patients Combined with Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2023, 26(26): 3246-3251. |
[15] | LU Zuowei, CAO Hongwei, LIU Tao, ZHANG Nana, CHEN Yanyan, SHI Qinli, LIU Xiangyang, WANG Qiong, LAI Jingbo, LI Xiaomiao. Development and Validation of a Risk Prediction Model for the Progression from Microalbuminuria to Macroalbuminuria in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(26): 3259-3268. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||